EHS
EHS

G+FLAS Life Sciences, a Korean CRISPR/Cas Genome Editing Company, Licenses DNA-Free Genome Editing Technologies




SEOUL, South Korea–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CRISPR?src=hash" target="_blank"gt;#CRISPRlt;/agt;–G+FLAS Life Sciences announced that they licensed two patents regarding Non-GMO ways of plant genome engineering.

Source link

EHS
Back to top button